Biohacking Pioneer Hails Common Nasal Spray as Potential Longevity Key
Dave Asprey, the founder of the biohacking movement, has highlighted new research suggesting that oxymetazoline, the active ingredient in the over-the-counter nasal spray Afrin, could be repurposed for anti-aging therapies. While the drug is known for causing rebound congestion if used excessively, studies indicate it may improve cell-to-cell communication, a key factor in aging. Asprey argues that major longevity breakthroughs may come from existing medications rather than new molecules, though experts caution that human trials are still years away.
